T EIT Health Prof. Josep Samitier IBEC Director Interim Director EIT Health Spain.

18
t EIT Health Prof. Josep Samitier IBEC Director Interim Director EIT Health Spain

Transcript of T EIT Health Prof. Josep Samitier IBEC Director Interim Director EIT Health Spain.

Page 1: T EIT Health Prof. Josep Samitier IBEC Director Interim Director EIT Health Spain.

t

EIT HealthProf. Josep Samitier IBEC DirectorInterim Director EIT Health Spain

Page 3: T EIT Health Prof. Josep Samitier IBEC Director Interim Director EIT Health Spain.

3

THE LUND DECLARATION 2009

European Research must focus on the Grand Challenges: AGEING

$ By 2060 one in three Europeans will be over 65 years.

$ The ratio between the employed and the unemployed will shift from today’s 4:1 to 2:1 by 2060.

$ Between 2010 and 2060 total government spending on pensions, healthcare, long term care and unemployment benefits will increase more than 4 percentage points of GDP.

$ Total expenditures for long-term care will double.

Page 4: T EIT Health Prof. Josep Samitier IBEC Director Interim Director EIT Health Spain.
Page 5: T EIT Health Prof. Josep Samitier IBEC Director Interim Director EIT Health Spain.
Page 6: T EIT Health Prof. Josep Samitier IBEC Director Interim Director EIT Health Spain.
Page 7: T EIT Health Prof. Josep Samitier IBEC Director Interim Director EIT Health Spain.

Our KIC-Health consortium spans across EuropeCo-location Centre

InnoSTAR Region

International HeadquarterCoordinator: Roche Diagnostics GmbH

52 Core Partners

92 Associated Partners

6 Colocations nodes (UK, Sweden, Germany, Benelux, France, Spain)

7 InnoStars regions (Wales, Portugal, Poland , Hungary, Slovenia, Croatia)

Page 8: T EIT Health Prof. Josep Samitier IBEC Director Interim Director EIT Health Spain.

Node regions

CatalunyaMadrid

Industry

CLC

València

EIT Health Spanish co-location centerThe Spanish node is formed by three regions (Catalunya, Madrid and Valencia) involving strong partners in the three areas of the innovation triangle: research, education and business

Page 9: T EIT Health Prof. Josep Samitier IBEC Director Interim Director EIT Health Spain.

Barcelona, home of our co-location centreAn innovative city

• Barcelona, winner of the European Capital of Innovation award 2014

• Barcelona and its metropolitan area concentrate 90% of the life sciences sector. The Catalan capital is home to 264 of the 512 companies in the BioRegion, 27 research centers working in the life

sciences, 4 university hospitals, 7 universities offering degrees in this arena and 7 science and technology parks.

• The concentration of biotechnology companies devoted to therapeutics and diagnostics is noteworthy (58% of the total), as is that of those devoted to R&D services (53%).

Page 10: T EIT Health Prof. Josep Samitier IBEC Director Interim Director EIT Health Spain.

IBEC Strategic plan: 3 focus programmes

IBEC's diverse research interests can be divided into three targeted areas of knowledge

– Nanomedicine, Cell Engineering, and ICT for Health –for applications in:

These 3 focus programmes promote interaction between IBEC's multidisciplinary groups and help the institute's research remain application-oriented.

Bioengineering for Future Medicine

Bioengineering for Regenerative Therapies

Bioengineering for Healthy Ageing

Page 11: T EIT Health Prof. Josep Samitier IBEC Director Interim Director EIT Health Spain.

IBEC: a benchmark in Bioengineering

The global ageing population will have considerable consequences, but biomedical engineering can contribute greatly to improving the quality of life of older people.

Assisted living technologies such as telecare, home-based devices and services that support daily life with a remote link to a call-centre, and telehealth – remote monitoring, consultation and diagnosis – can help support independent living at home, keeping patients out of hospital and residential care for longer.

Advances in sensors, signal treatment, data analysis, robotics and intelligent control systems at IBEC are enabling the development of remote care or assisted living, so that people with dementia or long-term health conditions can remain in their own homes.

Personalized therapies, combining new tailored nanobiomaterials with cell engineering drives advances in tissue engineering for the repair and replacement of human tissues damaged by injury, illness and ageing.

Bioengineering for Healthy Ageing

Page 12: T EIT Health Prof. Josep Samitier IBEC Director Interim Director EIT Health Spain.
Page 13: T EIT Health Prof. Josep Samitier IBEC Director Interim Director EIT Health Spain.

Challenges are further broken down

Promote Healthy Living

Self-management of health

Lifestyle intervention

Motivate active personal lifestyles

Metabolic Health

Support Active Ageing

Workplace interventions

Overcoming functional loss

Ageing with a Healthy Brain

Mobility and independence throughout

Life

Improve Healthcare

Improving healthcare systems

Treating and managing chronic diseases

Personalised Oncology and Integrated Cancer Care

Sustainable Continuum of Care to Support Active

Living in Europe

Business Objectives

Example projects

Page 14: T EIT Health Prof. Josep Samitier IBEC Director Interim Director EIT Health Spain.

14

Page 15: T EIT Health Prof. Josep Samitier IBEC Director Interim Director EIT Health Spain.

15

Page 16: T EIT Health Prof. Josep Samitier IBEC Director Interim Director EIT Health Spain.

16

Page 17: T EIT Health Prof. Josep Samitier IBEC Director Interim Director EIT Health Spain.

17

Page 18: T EIT Health Prof. Josep Samitier IBEC Director Interim Director EIT Health Spain.

eit.europa.eu